Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
6/1/2023
The U.S.-Chinese Economic Relationship Is Changing—But Not Vanishing ...
6/1/2023
NH's DB6: China's Consumer Healthcare Market Underperformed in 2022
6/1/2023
NH's DB6: Top Ten Chinese CHC Brands in 2021
6/1/2023
NH's DB6: Chinese Consumer Healthcare Market Forecast 2027/2032
6/1/2023
Edelman Report Finds Chinese Trusting Pharma the Most
5/31/2023
Sanofi Ups Bet on China with Plan to Enhance Manufacturing and Researc...
5/29/2023
A Share-Listed Chinese MedPharm Cos Report Performance in 2022 with Ov...
5/29/2023
Review of Leading Listed Chinese Pharma Cos by R&D Spending in 2022
5/22/2023
SMEI: Chinese Terminal Drug Market Growth Slowed to 1.1% in 2022 (Upda...
5/19/2023
An AstraZeneca Executive Said the Quiet Part about China Out Loud (Qua...
5/18/2023
Chinese A Shared-listed Pharma Companies Report Mixed Q1/2023 Performa...
5/16/2023
China's Top 10 Homegrown Novel Drugs in 2022, Vaccines and Cancer Drug...
5/5/2023
Reshoring and Nearshoring – Is China Still Relevant? (TMD)
5/4/2023
AstraZeneca Places Bet on COPD as COVID Vaccine Sales Fade
5/3/2023
Getting Novel Drugs to China Through Special Zones (thepharmaletter)
4/28/2023
AstraZeneca Eyes More China Deals After Signing Three Licensing Deals
4/26/2023
Why Rising Demand for Healthcare Is Creating Investment Opportunities ...
4/21/2023
AstraZeneca Oncology R&D Head On China Biotech Innovation - Looking Ag...
4/21/2023
NMPA Issues the 2022 Drug Regulatory Statistics Annual Report
4/12/2023
Yicai: Most Chinese Regions Eye Healthcare Industry Upgrades
4/12/2023
Outlook of China's Health Systems (Informa)
4/10/2023
FT: Astellas to Stay Put in China Despite Growing Geopolitical Tension
4/8/2023
South Korean Biotech Companies Seek to Diversify from China as US Tens...
4/8/2023
EU-China Relations – Trade, Investment, and Recent Developments (Chin...
4/1/2023
China Further Intensifies Healthcare Cost Containment and Price Contro...
3/29/2023
Investing in China's Healthcare Sector (China Briefing)
3/15/2023
Deloitte: 2023 China LSHC Investment and M&A Market Outlook
3/9/2023
PhIIC: Chinese Retail Pharmacy Sales Fell Sharply in 2022 Despite Rebo...
2/24/2023
SMEI: Chinese Pharma Revenues Down 1.6% Last Year But Expected to Rebo...
2/24/2023
IQVIA: Chinese Hospital Drug Market Shrank 2.1% in 2022
Page:
7
/
38
Total number of articles:
1139
:
[First]
[<<]
[5]
[6]
[7]
[8]
[9]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit